Table 2.
Prior therapies | No. of pts (n = 30) | % |
---|---|---|
Cytotoxics | ||
5-fluorouracil | 23 | 77 |
Taxanes | 17 | 57 |
Irinotecan | 16 | 53 |
Capecitabine | 12 | 40 |
Anthracyclines | 11 | 37 |
Oxaliplatin/Cisplatin/Carboplatin | 10/3/6 | 33/10/20 |
Cyclophosphamide | 7 | 23 |
Gemcitabine | 6 | 20 |
Navelbine | 5 | 17 |
Other | 3 | 10 |
Targeted agents | ||
Bevacizumab | 14 | 47 |
Cetuximab and Panitumamab (Vecitibix) | 11 | 37 |
Cetuximab | 8 | 27 |
Herceptin | 4 | 13 |
Gefitinib/Lapatinib | 2/2 | 7/7 |
Other | 10 | 33 |
Hormonal therapy | ||
Tamoxifen | 4 | 13 |
Arimidex | 5 | 17 |
Other | 4 | 13 |